Business news – Page 80
-
Business
UK regulator warning over online herbal remedies
Products found to contain toxic metals or undeclared prescription-only drugs
-
Business
Insider trading allegations stall Sun–Ranbaxy deal
Companies deny wrongdoing in lead-up to merger announcement
-
Business
Forest Labs buys Furiex for bowel drug
Firm will immediately sell on other assets to Royalty Pharma
-
Business
BASF to cut 260 jobs in nutrition and health
Firm to sell Norwegian site and shift focus towards Asia
-
OpinionEngineering serendipity
It takes more than random stumbling to find new reactions, says Derek Lowe
-
OpinionFrack and blue
Shale gas will do little to improve the competitiveness of Europe’s chemical industry, argues Mark Peplow
-
Business
Generics triumph in anti-inflammatory patent battle
Pfizer settles deals to allow copycat celecoxib
-
Business$25bn-plus trade sharpens pharma giants’ focus
Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
-
Business
GSK corruption investigation widens
BBC investigation airs allegations of misconduct in Poland
-
BusinessMissing safety risk emails draw $9bn Actos fine
Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
-
BusinessSun set on Ranbaxy rescue
Acquiring beleaguered firm will create India’s biggest pharmaceutical company
-
Business
GSK investigates bribery claims in the Middle East
Leaked emails claim GlaxoSmithKline bribed Iraqi doctors and healthcare officials
-
Business
Anadarko agrees $5bn clean-up settlement
Record fine will address pollution at mining and manufacturing sites across the US.
-
Business
Contamination troubles strike GSK
GlaxoSmithKline is warned over contamination at an Ireland plant, and has recalled Alli from US retailers over tampering concerns.
-
Business
Lilly wins cancer drug patent dispute
Alimta patent will last until 2022 after US court rules in Lilly’s favour
-
Business
Pharma giants plan new public–private collaborations
AstraZeneca and GSK will partner with UK academics to work on early drug discovery
-
Business
Baxter aims to divide and conquer
Firm will split off its biopharmaceuticals business from medical products
-
Business
Grangemouth will switch to shale gas feed by 2016, says Ineos
New terminal will take US ethane imports and outdated plants will shut down